Denmark is building Europe’s leading ecosystem for medical cannabis
Patients and their doctors are actively exploring ways of incorporating medical cannabis into treatment options, while academic and clinical researchers are exploring the efficacy of medical cannabis to treat a range of conditions for which there is initial evidence of potential benefits.
It should be noted that doctors and patients are able to access cannabis products through the pilot program, but also through magistral preparations at specialised pharmacies and through pharmaceutical approved products.
Dynamic cultivation of medical cannabis under the development scheme
Denmark uses an open-ended system with no limits on the number of cultivators as long as high standards are maintained, no caps on production volumes, and straight-forward first authorization to handle and cultivate medical cannabis.
This allows companies to set up quickly while innovating and developing sustainable cultivation techniques and business models. As of mid-2020, over 40 companies have been granted permission to cultivate and handle medical cannabis as long as high standards of quality are maintained.
Denmark is on track to be one of the world’s largest GACP cultivation nations with more than 200,000 square meters/3 million SQF of cultivation on its way to being built out, all based on high standards of GMP and GACP frameworks.
Top reason for choosing Denmark for medical cannabis activities
Want to know more about medical cannabis industry in Denmark?
Please contact our dedicated advisors here: